Title:
C-4''-SUBSTITUTED MACROLIDE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2016/027755
Kind Code:
A1
Abstract:
A compound of the following formula [1], which possesses good antimicrobial activity against erythromycin-resistant bacteria, such as resistant pneumococci, streptococci and mycoplasma, against which conventional macrolide antibiotics do not possess sufficient antimicrobial activity. Also provided is a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof.
Inventors:
SUGIMOTO TOMOHIRO (JP)
HAYASHI MASATO (JP)
KAWAGUCHI TAKANORI (JP)
HAYASHI MASATO (JP)
KAWAGUCHI TAKANORI (JP)
Application Number:
PCT/JP2015/072993
Publication Date:
February 25, 2016
Filing Date:
August 17, 2015
Export Citation:
Assignee:
TAISHO PHARMACEUTICAL CO LTD (JP)
International Classes:
C07H17/08; A61K31/7048; A61P31/04
Foreign References:
| JP2014505723A | 2014-03-06 | |||
| JP2014058509A | 2014-04-03 | |||
| JP2014058508A | 2014-04-03 | |||
| JP2014058507A | 2014-04-03 |
Other References:
See also references of EP 3192798A4
Attorney, Agent or Firm:
SIKs & Co. (JP)
Patent business corporation patent firm Sykes (JP)
Patent business corporation patent firm Sykes (JP)
Download PDF:
Previous Patent: ACID-ADDITION SALT OF Trk-INHIBITING COMPOUND
Next Patent: SURGICAL ABSORBENT ARTICLE, DETECTION DEVICE, AND DETECTION METHOD
Next Patent: SURGICAL ABSORBENT ARTICLE, DETECTION DEVICE, AND DETECTION METHOD